Medication adherence of individuals with a first episode of psychosis

被引:342
作者
Coldham, EL
Addington, J
Addington, D
机构
[1] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada
[2] Univ Calgary, Dept Psychiat, Calgary, AB, Canada
关键词
patient non-adherence; schizophrenia; drug utilization; psychotic disorders;
D O I
10.1034/j.1600-0447.2002.02437.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To determine rates of adherence to antipsychotic medication in first episode patients and the correlates of adherence in this group. Method: Subjects were the first 200 admissions to an Early Psychosis Program. Adherence was determined on a three-point scale. Symptoms, medication side-effects, quality of life, substance use and family involvement were examined longitudinally. Results: In their first year in the program 39% were non-adherent, 20% inadequately adherent, and 41% adherent. Non-adherent patients demonstrated more positive symptoms, more relapses, more alcohol and cannabis use, reduced insight, and poorer quality of life. They were younger, had an earlier age of onset and less likely to have a family member involved in treatment. Conclusion: Results for this group are similar to those reported in the literature. Correlates are often the consequence of non-adherence. Non-compliance has to be anticipated and relationships maintained with patients and families to intervene as soon as possible to minimize the consequence of non-compliance.
引用
收藏
页码:286 / 290
页数:5
相关论文
共 36 条
[11]   DIAGNOSIS OF ALCOHOL-USE DISORDERS IN SCHIZOPHRENIA [J].
DRAKE, RE ;
OSHER, FC ;
NOORDSY, DL ;
HURLBUT, SC ;
TEAGUE, GB ;
BEAUDETT, MS .
SCHIZOPHRENIA BULLETIN, 1990, 16 (01) :57-67
[12]  
Favre S, 1997, EUR J PSYCHIAT, V11, P35
[13]   Determinants of medication compliance in schizophrenia: Empirical and clinical findings [J].
Fenton, WS ;
Blyler, CR ;
Heinssen, RK .
SCHIZOPHRENIA BULLETIN, 1997, 23 (04) :637-651
[14]   Compliance with neuroleptic medication in outpatients with schizophrenia; Relationship to subjective response to neuroleptics; Attitudes to medication and insight [J].
Garavan, J ;
Browne, S ;
Gervin, M ;
Lane, A ;
Larkin, C ;
O'Callaghan, E .
COMPREHENSIVE PSYCHIATRY, 1998, 39 (04) :215-219
[15]  
Hayward P, 1995, J MENTAL HLTH, V4, P511, DOI [DOI 10.1080/09638239550037343, 10.1080/09638239550037343]
[16]   Cost-effectiveness evaluation of compliance therapy for people with psychosis [J].
Healey, A ;
Knapp, M ;
Astin, J ;
Beecham, J ;
Kemp, R ;
Kirov, G ;
David, A .
BRITISH JOURNAL OF PSYCHIATRY, 1998, 172 :420-424
[17]   THE QUALITY OF LIFE SCALE - AN INSTRUMENT FOR RATING THE SCHIZOPHRENIC DEFICIT SYNDROME [J].
HEINRICHS, DW ;
HANLON, TE ;
CARPENTER, WT .
SCHIZOPHRENIA BULLETIN, 1984, 10 (03) :388-398
[18]   Psychopharmacology: Insight and comorbid substance misuse and medication compliance among patients with schizophrenia [J].
Kamali, M ;
Kelly, L ;
Gervin, M ;
Browne, S ;
Larkin, C ;
O'Callaghan, E .
PSYCHIATRIC SERVICES, 2001, 52 (02) :161-+
[19]   The reliability of compliance assessments performed by doctors and patients during neuroleptic treatment: a comparison of compliance ratings [J].
Kampman, O ;
Lehtinen, K ;
Lassila, V .
ACTA PSYCHIATRICA SCANDINAVICA, 2001, 104 (04) :299-304
[20]   THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) FOR SCHIZOPHRENIA [J].
KAY, SR ;
FISZBEIN, A ;
OPLER, LA .
SCHIZOPHRENIA BULLETIN, 1987, 13 (02) :261-276